Results 161 to 170 of about 115,023 (299)

Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen‐Specific Immune Responses

Allergy, EarlyView.
We used PBMC transcriptome from 50 hen's egg‐allergic patients to study the role of lncRNA in OIT. Positive correlation was found between 17 lncRNAs and the IL‐4/IL‐13 pathway in vivo, and the expression of the selected lncRNA aligned with CXCL8 upon PBMC egg‐restimulation.
Olivia Liong, Kati Palosuo, Victoria Hinkkanen, Vittorio Fortino, Mika J. Mäkelä, Piia Karisola   +5 more
wiley   +1 more source

Cost-effectiveness of antihistaminics in adults' patients with allergic rhinitis. [PDF]

Cost Eff Resour Alloc
Buendía JA, Patino DG.
europepmc   +1 more source

Efficacy of allergen-specific immunotherapy for allergic rhinitis: a meta-analysis. [PDF]

Front Med (Lausanne)
Wang D, Song D, Xu X.
europepmc   +1 more source

Efficacy of Chinese herbal medicine in allergic rhinitis: a meta-analysis. [PDF]

Braz J Otorhinolaryngol
Zhu H, Wang Y, Zhang H, Kang Q, Xu L, Chen J, Chen C, Tao J.   +7 more
europepmc   +1 more source

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

Allergy, EarlyView.
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau, Marcus Maurer, Adam Reich, Chia‐Yu Chu, Diana Deleanu, Gordon Sussman, Jorge Sanchez, Knut Brockow, Koremasa Hayama, Michihiro Hide, Mohamed Denguezli, Raisa Meshkova, Roberta F. J. Criado, Sarbjit Saini, Solange Valle, Eva Hua, Pengpeng Wang, Alis Burciu, Isabelle Indermuehle, Vineeth Varanasi, Yolandi Joubert, Thomas Severin, Manmath Patekar   +22 more
wiley   +1 more source

Characterising the allergen landscape in paediatric allergic rhinitis and/or asthma. [PDF]

BMJ Open Respir Res
Chen Y, Zhou X, Wang Y, Wang Y, Jiawei R, Long Y, Wu J.   +6 more
europepmc   +1 more source

Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III Trial

Allergy, EarlyView.
The RHAPSODY multinational study investigated 26 months of continuous treatment with 5‐grass‐pollen sublingual SLIT drops in adults with moderate‐to‐severe grass‐pollen‐induced allergic rhinoconjunctivitis. The primary efficacy endpoint (the average daily total combined score) showed statistically significant differences in favour of the active ...
Alain Didier, Ruta Gronskyte Juhl, Terrie Dalgaard, Antoine Chartier, Philippe Devillier   +4 more
wiley   +1 more source

Matcha alleviates sneezing response in a murine model of allergic rhinitis. [PDF]

NPJ Sci Food
Ogata S, Uda N, Miura K, Enkhbaatar U, Yamasaki N, Hosomi N, Mori A, Hasebe R, Matsuda N, Higashikawa F, Gamboa M, Nakajima S, Kitamura N, Gotoh M, Sekizawa SI, Kaminuma O.   +15 more
europepmc   +1 more source

Dissemination and implementation of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis in general and specialist practice [PDF]

, 2013
Van Hoecke, Helen
core  

Art v 1 and Amb a 4 Co‐Sensitization Identifies Italian Patients at Risk for Mugwort‐Celery‐Spice Syndrome

Allergy, EarlyView.
Three molecular profiles identified among Art v 1/Amb a 4‐sensitized patients: Art v 1 monosensitization, Amb a 4 monosensitization, and dual sensitization to both allergens. Art v 1 monosensitization was predominantly associated with allergic rhinitis, reflecting a classical airborne allergy pattern.
Enrico Scala, Gabriella Cusa, Valeria Villella, Damiano Abeni, Mauro Giani, Emma Cristina Guerra, Maria Locanto, Giorgia Meneguzzi, Lia Pirrotta, Donato Quaratino, Alessandra Zaffiro, Elisabetta Caprini, Maria Barrale, Ignazio Brusca, Valerio Pravettoni, Lorenzo Cecchi, Danilo Villalta, Martina Aumayr, Irene Mittermann, Christian Lupinek, Riccardo Asero   +20 more
wiley   +1 more source